Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$242.49 - $301.46 $437,694 - $544,135
-1,805 Reduced 12.6%
12,519 $3.08 Million
Q2 2022

Aug 04, 2022

SELL
$224.73 - $338.64 $305,408 - $460,211
-1,359 Reduced 8.67%
14,324 $3.55 Million
Q1 2022

May 13, 2022

SELL
$277.25 - $366.29 $1.46 Million - $1.93 Million
-5,274 Reduced 25.17%
15,683 $5.2 Million
Q4 2021

Feb 10, 2022

BUY
$300.63 - $371.35 $877,839 - $1.08 Million
2,920 Added 16.19%
20,957 $7.53 Million
Q3 2021

Nov 12, 2021

BUY
$310.19 - $376.2 $984,543 - $1.19 Million
3,174 Added 21.36%
18,037 $5.87 Million
Q2 2021

Aug 10, 2021

SELL
$262.71 - $351.17 $998,823 - $1.34 Million
-3,802 Reduced 20.37%
14,863 $4.64 Million
Q1 2021

May 13, 2021

SELL
$285.92 - $355.13 $164,404 - $204,199
-575 Reduced 2.99%
18,665 $5.95 Million
Q4 2020

Feb 10, 2021

SELL
$251.88 - $324.2 $893,166 - $1.15 Million
-3,546 Reduced 15.56%
19,240 $6.24 Million
Q3 2020

Nov 12, 2020

SELL
$255.22 - $317.0 $372,110 - $462,186
-1,458 Reduced 6.01%
22,786 $6.31 Million
Q2 2020

Aug 13, 2020

SELL
$141.4 - $257.09 $2.32 Million - $4.21 Million
-16,385 Reduced 40.33%
24,244 $5.86 Million
Q1 2020

May 14, 2020

BUY
$130.51 - $196.01 $1.95 Million - $2.93 Million
14,959 Added 58.27%
40,629 $5.9 Million
Q4 2019

Feb 10, 2020

BUY
$159.31 - $223.54 $1.59 Million - $2.23 Million
9,981 Added 63.62%
25,670 $4.38 Million
Q3 2019

Nov 12, 2019

SELL
$175.89 - $279.23 $18,116 - $28,760
-103 Reduced 0.65%
15,689 $2.79 Million
Q2 2019

Jul 30, 2019

SELL
$250.96 - $284.94 $78,801 - $89,471
-314 Reduced 1.95%
15,792 $4.11 Million
Q1 2019

May 14, 2019

BUY
$276.39 - $362.25 $33,719 - $44,194
122 Added 0.76%
16,106 $4.6 Million
Q4 2018

Feb 12, 2019

SELL
$281.08 - $444.25 $1.28 Million - $2.02 Million
-4,543 Reduced 22.13%
15,984 $5.2 Million
Q3 2018

Nov 13, 2018

BUY
$354.53 - $449.75 $7.28 Million - $9.23 Million
20,527 New
20,527 $9.23 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Aviva PLC Portfolio

Follow Aviva PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.